MENU
Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Oct 25, 2023

Trader Robot Strikes Again with +5.44% Weekly Gain on $ACET

In the world of AI trading robots, the "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" has become a popular choice for investors. These sophisticated bots have been making waves in the financial market, recently delivering impressive results. During the previous week, these trading bots managed to secure a remarkable gain of +5.44% while actively trading ACET. In this article, we will delve into the specifics of ACET's earnings and market trends, shedding light on what's driving the success of these AI trading robots.

MACD Indicator: A Positive Omen for ACET

One of the key factors contributing to the success of the AI trading bots is the analysis of the Moving Average Convergence Divergence (MACD) indicator for ACET. On October 5, 2023, the MACD Histogram for ACET crossed above the signal line, signaling a positive trend. This is a significant technical indicator that often piques the interest of traders.

Historical data shows that when ACET's MACD turns positive, the stock tends to continue its upward trajectory. Out of 39 instances where the MACD turned positive, ACET's stock price rose in 34 of them over the following month. This historical data indicates an impressive 87% success rate for predicting an upward trend in ACET's stock price.

Earnings Report: A Mixed Bag for ACET

One critical aspect that AI trading bots consider when making trading decisions is the company's earnings. ACET reported its last earnings on August 09, which showed earnings per share (EPS) of -75 cents. This result fell short of the estimated -46 cents, highlighting a significant earnings miss.

To put this in perspective, with 153.57K shares outstanding, the current market capitalization for ACET stands at 64.60M. This earnings report will undoubtedly have an impact on the trading strategies employed by AI bots.

Dividend Dates and Their Implications

Investors often consider dividends when making trading decisions. ACET paid a quarterly dividend of $0.01 per share, with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. The ex-dividend date is an important factor to consider. If you buy a stock on or after this date, you won't receive the next dividend payment. Instead, the dividends are retained by the seller. However, if you purchase the stock before the ex-dividend date, you will receive the dividends.

Market Capitalization Insights

Understanding a company's market capitalization is crucial for investors. In the biotechnology industry, ACET's market capitalization of 64.60M places it on the lower end of the spectrum. The average market capitalization for companies in this industry is 2.19B, with a wide range of values, from 402M to 429.71B. For comparison, the highest-valued company in this group is NVO at 429.71B, while the lowest is PNEXF at 402M.

Price Trends and Volatility in the Biotechnology Industry

Market trends play a significant role in the success of AI trading bots. In the biotechnology industry, the average weekly price growth for all stocks was -3%, indicating a slight decline. The average monthly price growth was -5%, while the average quarterly price growth was -15%. These figures suggest a challenging environment for traders in this industry.

Notably, ADXN experienced the highest price growth at a staggering 1,510%, showcasing the potential for significant gains in the biotech sector. Conversely, ATHX experienced a substantial decline, with a -82% drop in its stock price, highlighting the industry's inherent volatility.

Volume: An Indicator of Trading Activity

Trading volume is a crucial indicator for traders and AI trading bots. In the biotechnology industry, the average weekly volume growth for all stocks was -25%, suggesting a decline in trading activity. On a monthly basis, the average volume growth was -6%, indicating a persistent downtrend. However, the quarterly volume growth was a notable exception, showing a significant 72% increase in trading activity.

In summary, the success of AI trading robots is often attributed to their ability to analyze a plethora of data, including technical indicators, earnings reports, market trends, and trading volumes. The positive MACD crossover for ACET, despite a recent earnings miss, suggests a potential upward trend. However, the broader trends in the biotechnology industry and trading volumes indicate a more challenging environment.

Related Ticker: ACET

ACET in +7.97% Uptrend, rising for three consecutive days on October 16, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACET advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on October 16, 2024. You may want to consider a long position or call options on ACET as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ACET turned negative on October 25, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

ACET moved below its 50-day moving average on October 23, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACET crossed bearishly below the 50-day moving average on September 27, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACET broke above its upper Bollinger Band on October 22, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.505) is normal, around the industry mean (12.657). P/E Ratio (0.000) is within average values for comparable stocks, (111.595). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.971). ACET has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (225.870).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (null:REGN), Moderna (null:MRNA), Incyte Corp (null:INCY), Sarepta Therapeutics (null:SRPT), Exelixis (null:EXEL), Arrowhead Pharmaceuticals (null:ARWR), Novavax (null:NVAX), BioCryst Pharmaceuticals (null:BCRX), Adaptive Biotechnologies Corp (null:ADPT), Nektar Therapeutics (null:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.92B. The market cap for tickers in the group ranges from 151 to 531.34B. NONOF holds the highest valuation in this group at 531.34B. The lowest valued company is MYMX at 151.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -6%. MNPR experienced the highest price growth at 240%, while BICTF experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 59
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
ACET
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com
Ad is loading...
In July, Apple (NASDAQ: AAPL) made history as the first company to close regular-session trading with a market capitalization exceeding $3.5 trillion. Despite early session declines, Apple stock reached an all-time high of $229.40 and closed at $228.68.
Swing trading involves holding positions for several days to weeks to capture gains from market movements that unfold over a medium-term horizon. This strategy relies on technical analysis to identify potential entry and exit points, often supplemented by fundamental analysis to strengthen trade decisions.
The cleaning sector has exhibited a notable performance increase, experiencing a +4.71% rise over the past week. This performance surge reflects positive market sentiment and possibly increasing demand within the sector.
The immuno-oncology sector, comprising companies that develop advanced technologies for cancer treatment, has shown promising performance recently. This sector's innovation and critical role in advancing cancer treatments have led to a significant market response, reflected in a notable +8.04% increase in performance over the past week. Below is an analysis of the key players in this group—Corvus Pharmaceuticals (CRVS), AnaptysBio (ANAB), and iTeos Therapeutics (ITOS)—focusing on market capitalization, price movements, volume changes, and technical indicators.
U.S. stocks took a hit as tech shares dropped and the yen strengthened, leading to a 1,033-point drop in the Dow. With growing concerns over the Fed's rate policy, analysts now predict multiple rate cuts to address rising economic risks.
The technology sector remains a dynamic space for investors, with certain themes like portable devices showing substantial growth potential. Over the past week, the portable devices theme has seen an impressive performance with a +14.86% increase, highlighting the strength and resilience of companies operating within this sector. In this article, we will explore key metrics such as market capitalization, price trends, and volume growth, while also taking a closer look at the individual performances of companies within this theme, particularly focusing on Apple Inc. (AAPL), CEVA Inc. (CEVA), and Generac Holdings Inc. (GNRC).
The performance of companies in the fish-selling category has attracted significant attention recently, primarily due to the group's impressive +19.69% increase in performance over the past week. The 'fish' category, which includes companies that sell or produce fish, often overlaps with firms involved in poultry, frozen meat, and dairy products. Notable companies in this sector include Lifeway Foods, Inc. (LWAY), Sanderson Farms, Inc., and Hormel Foods Corp. (HRL). In this article, we will explore the market dynamics, price movements, and volume changes affecting this sector, with a focus on the group of tickers HRL, LWAY, BRFS, and PPC.
Two standout models are at the core of Tickeron's new bots (robots). Identifying and acting on price drops ("search for dips") and leveraging significant volatility spikes.
Tickeron has introduced advanced AI trading bots designed for day traders, utilizing Financial Learning Models (FLMs) and technical analysis to optimize strategies in high-volatility markets. These bots are engineered to capitalize on price surges and provide precise, short-term trading opportunities.
The railroads sector has recently demonstrated impressive performance, with a notable +19.69% increase in performance over the past week. This surge underlines the sector's critical role in freight and passenger transportation across North America, providing essential infrastructure for both national and international trade logistics. This article delves into the sector's key players, their market performance, and recent trends that are shaping the future of rail transport.
The uranium sector has been gaining notable attention recently, with a sharp uptick in performance. As of last week, uranium companies have seen a significant increase in performance by +10.69%. This surge brings renewed focus to uranium, a critical element used in nuclear power generation. With nuclear energy gaining traction as a cleaner alternative, companies engaged in uranium acquisition, exploration, and development are well-positioned to capitalize on this demand.
Amazon (AMZN) saw a $54B market cap increase this week, driven by a 2.74% stock price surge. Despite the short-term volatility indicated by breaking its upper Bollinger Band, the company's strong positioning in AI and cloud computing continues to attract investor interest.
The financial markets saw a mix of gains and declining volatility between September 23-27, with key indexes like SPY, QQQ, and DIA posting positive returns. Despite rising stocks, volatility measures dropped, reflecting reduced market uncertainty. This article explores market trends and highlights AI-driven trading robots designed to capitalize on opportunities while managing risk.
Tickeron's AI-powered Trend Trading bots are revolutionizing stock investing by integrating Financial Learning Models (FLMs) to help hedge fund managers and traders uncover undervalued stocks. These bots provide actionable signals, apply advanced risk management strategies, and support disciplined growth, empowering investors to navigate complex financial markets with ease.
The aluminum construction companies have experienced a significant boost, with the segment seeing a +11.13% increase in performance over the past week. This growth is largely driven by the rising demand for lightweight materials, particularly in the automotive sector, where aluminum is being widely adopted to improve fuel efficiency. The aluminum industry plays a vital role in the U.S. economy, generating approximately $71 billion annually in direct economic impact, according to The Aluminum Association.
Unlock the potential of AI-powered swing trading with robots designed to track dips in top S&P 500 stocks. Whether you're a beginner or experienced trader, these tools help manage up to $20k per position, balancing risk and reward with advanced algorithms and market insights. Discover how to maximize returns in volatile markets!
Discover Tickeron's new AI-driven trading bots designed for high-volatility markets and impulse price action. Leveraging Financial Learning Models (FLMs) and technical analysis, these bots optimize trades, offer a 70% win rate, and execute strategies for day traders focused on fast market moves.
The Diesel Companies segment has displayed a notable increase of +9.44% in performance over the past week. This uptick highlights a positive trend in the sector, encompassing companies involved in the manufacturing of diesel vehicles and the distribution of transportation fuels.